Revolutionary Strategies in Orphan Drug Development with Isabel Rubio
In this episode, we invite Access Infinity Partner, Isabel Rubio back to the podcast to explore the unique challenges and innovative solutions reshaping market access and pricing within rare disease. Isabel shares insights from her extensive experience with due diligence assessments in orphan drug development, discussing three transformative strategies that are revolutionising how companies prove value in ultra-rare diseases. From multi-domain endpoints and visual evidence to payment-by-results models, this episode reveals why traditional HTA frameworks fall short for orphan drugs and how early collaboration between pricing, market access, and clinical teams is essential for success. Isabel has authored a blog on this topic, which you can read here: accessinfinity.com/blogs/breaking-through-barriers-how-innovation-is-revolutionising-orphan-drug-development. Send us a text
--------
18:29
--------
18:29
Elevating launch excellence: The strategic value of early market access involvement with Lizzie Shanahan, Sanofi
In this insightful episode we speak with Lizzie Shanahan, Global Access AI Strategy Lead at Sanofi. With over six years' experience at Sanofi and a rich background in commercial roles, Lizzie shares her unique journey into the world of market access and how her diverse experience shapes her approach to launch excellence.The conversation explores exciting developments in the industry, including the evolution of digital technologies and AI. Lizzie shares thoughtful insights on finding the right balance between technological innovation and maintaining essential human skills within the industry.This is a great episode for professionals in market access or commercial leaders considering a career transition and provides both practical guidance and forward-thinking perspectives on the changing landscape of market access.The opinions shared in this podcast are Lizzie's own views. Send us a text
--------
30:22
--------
30:22
Getting ready for the JCA: Why cross-functional collaboration matters with Silvy Mardiguian, BeiGene
In this episode, we speak with Silvy Mardiguian, Senior Director and Head of HEOR for Europe & New Markets at BeiGene. Silvy has been co-leading BeiGene’s preparedness and organisational readiness for the new Joint Clinical Assessment (JCA) framework, which is going to significantly change the EU HTA landscape.Silvy shares key insights into some of the learnings and challenges she has encountered during this process and highlights why strong cross-functional collaboration has been key to making it all work.We also hear about Silvy’s career journey to date — from her move from consulting into industry to the lessons she’s picked up along the way. She shares advice for anyone working in value and access, as well as some words of wisdom she’d give her younger self. The opinions shared in this podcast are Silvy's own views. Send us a text
--------
18:35
--------
18:35
The rise of multi-stakeholder capitalism in market access with Jie Shen, CSL
In this episode we chat with Jie Shen, who is Vice President Global Head Market Access at CSL. Having started her career in pharma before the market access function existed, Jie is an industry veteran. We cover the changes she's seen over the last 24 years, including multi-stakeholder capitalisation - what it means to Jie and why she feels it's important for market access leaders.The opinions shared in this podcast are Jie's own views.Send us a text
--------
13:37
--------
13:37
Authentic leadership in Market Access with Katrin Jack, Galderma
We're kicking off 2025 with a fantastic podcast episode featuring Katrin Jack, Global Access Strategy Head at Galderma and President of the Healthcare Businesswomen's Association Zürich-Zug Chapter. This episode covers a lot of ground, from the 'sliding doors' moment that led Katrin into market access, to why she feels it's important for leaders to understand their core values (and stay true to them). Like many of our podcast guests, Katrin has an obvious passion for market access and it was a delight to hear about her journey and the perspectives she's gained along the way. Bonus: In addition to the many professional insights Katrin shares in this chat, she also references the following book: "Beginner with a Black Belt" by Ana Stevanović. The opinions shared in this podcast are Katrin's own views.Send us a text
Brought to you by the team at Access Infinity, this podcast shines a spotlight on the people in market access. In each episode we interview a different industry professional to discover their journey into market access, what inspires them and what they feel is on the horizon for this this ever-changing and exciting industry.
France